Severe co-morbid illness such as untreatable other malignancy and/or active infections.
Pregnant or lactating women
Hypersensitivity to Sandostatin or any component of the formulation.

NCT02427295_exc_T1
Condition
co-morbid illness
NCT02427295_exc_T2
Qualifier
Severe
NCT02427295_exc_T3
Qualifier
untreatable
NCT02427295_exc_T4
Qualifier
other
NCT02427295_exc_T5
Condition
malignancy
NCT02427295_exc_T6
Qualifier
active
NCT02427295_exc_T7
Condition
infections
NCT02427295_exc_T8
Scope
untreatable other malignancy and/or active infections
NCT02427295_exc_T9
Scope
Severe co-morbid illness
NCT02427295_exc_T10
Condition
Pregnant
NCT02427295_exc_T11
Condition
lactating
NCT02427295_exc_T12
Person
women
NCT02427295_exc_T13
Condition
Hypersensitivity
NCT02427295_exc_T14
Drug
Sandostatin
NCT02427295_exc_T15
Drug
component of the formulation
NCT02427295_exc_T16
Scope
Sandostatin or any component of the formulation